AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesIACLRNCT04366362

Individualized Anterior Cruciate Ligament Versus Conventional Reconstruction

A study testing Individualised ACL reconstruction and Conventional ACL reconstruction in people with Anterior Cruciate Ligament Injuries, run by Larissa University Hospital at 1 site in Greece.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A randomised prospective control trial comparing the efficiency of a more individualized approach in ACL reconstruction with the help of neuromuscular computer models with traditional ACL reconstruction practices. Read more about this study

Who is it for?
Ages 14 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Anterior Cruciate Ligament Injuries
What is being tested?
Individualised ACL reconstruction and Conventional ACL reconstruction
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteGreece
Study dates
2 Mar 2020to Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Patients with ACL rupture undergoing ACL reconstruction surgery with closed epiphyses, younger than 45 years old

Who cannot join

  • No previous surgery in the knee (except partial meniscectomy), no major systematic pathology

Trial locations and contacts

1 site in 1 country.

Georgios Chalatsis, MD contact

00306977992086

ghalatsis@hotmail.com

michael hantes, MD contact

hantesmi@otenet.gr

Greece1 site, 1 recruiting
  • Michael Hantes

    Larissa

    Gorgios Paraskevas Chalatsis, MD, 0030 6977992086, ghalatsis@hotmail.com

    Michael Hantes, MD, hantesmi@otenet.gr

    Recruiting

Other trials in Greece

About this study

Official title: Anterior Cruciate Ligament Surgical Reconstruction Based on Individualized Musculoskeletal Models: a Randomized Control Trial

A randomised prospective control trial comparing the efficiency of a more individualized approach in ACL reconstruction with the help of neuromuscular computer models with traditional ACL reconstruction practices.

Read the detailed description

Until now the ACL reconstruction was based on the surgeon's experience. An individualised ACL reconstruction is customized based on each patient's special characteristics. Preoperative and intraoperative evaluation of the native ACL (both anteromedial and posterolateral bundles), knee anatomy and function, level of activity and generalised ligamentous laxity are assessed. Femoral and tibial tunnels should be placed in their anatomical location accounting for both the native ACL insertion site and bony landmarks. Two groups will be created, one with patients undergoing ACL reconstruction based on a surgeon's experience and one based on a more individualised approach according to the particular characteristics of each patient separately. In addition, patients in the second group will undergo ACL reconstruction with the use of Computer Assisted System (Navigation).

Preoperatively and postoperatively, the patients will be assessed with the KT2000 system, the KOOS (Knee injury and Osteoarthritis Outcome), the Tegner- Lysholm Knee scoring system and the IKDC (International Knee Documentation Committee). Additionally, all patient will be examined for their knee function with the use of a 3D gait analysis system.

The follow-up examination will take place 6 and 12 months after the surgery.

Being tested
Individualised ACL reconstruction, Conventional ACL reconstruction
Keywords
ACL, Anterior, Cruciate, Ligament, Reconstruction, Individualised, Anatomical, Navigation
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Individualised ACL reconstructionProcedure or surgery

    ACL reconstruction based on anatomical and functional distinctiveness of each patient separately

  • Conventional ACL reconstructionProcedure or surgery

    ACL reconstruction based on surgeons experience without taking into account any other patients characteristics

Study groups in NCT04366362
Study groupRoleWhat they receive
Convetional reconstruction groupActive comparatorPatients will undergo ACL reconstruction based on conventional ACL surgery
Receives: Procedure: Conventional ACL reconstruction
Individualised reconstruction groupExperimentalPatients will undergo ACL reconstruction based on their special anatomical and functional characteristics and with the use of a navigation system
Receives: Procedure: Individualised ACL reconstruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of the change of stability of the operated knee between the two groups from Baseline until 1 year post-operation

    Participants in two groups will be assessed with KT2000 arthrometer before and after ACL reconstruction regarding knee stability. Additionally knee kinematics and gait analysis before and after the ACL reconstruction will be compared between the two groups in a gait analysis lab.

    Measured: Baseline and 1 year post operation

Secondary outcomes (4)
  1. Compare the change from Baseline between the patients of the two groups in KOOS (Knee Injury & Osteoarthritis Outcome) from the baseline until 1 year post operation

    Originally published in 1998 in The Journal of Orthopaedic and Sports Physical Therapy, the Knee injury and Osteoarthritis Outcome Score (KOOS) assesses patient pain (9 items), other symptoms (7 items), function in daily living (17 items), function in sport and recreation (5 items), and knee related quality of life (4 items). Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. The KOOS is a patient reported joint-specific score, which may be useful for assessing changes in knee pathology over time, with or without treatment.

    Measured: Baseline and 1 year post operation

  2. Compare the change from Baseline between the patients of the two groups in IKDC (International Knee Documentation Committee Subjective Knee Form) from the baseline until 1 year post operation.

    the International Knee Documentation Committee Subjective Knee Form (IKDC) was designed to assess patients with a variety of knee disorders including ligamentous and meniscal injuries as well as patellofemoral pain and osteoarthritis. The IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

    Measured: Baseline and 1 year post operation

  3. Compare the change from Baseline between the patients of the two groups in Tegner Lysholm Knee Scoring Scale from the baseline until 1 year post operation.

    Lysholm Knee Scoring Scale was designed to be used for evaluating outcomes of knee ligament surgery, particularly for symptoms related to instability. The Lyshom Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. Scores range from 0 (worse disability) to 100 (less disability).

    Measured: Baseline and 1 year post operation

  4. Compare the post operation MRI of the 2 groups

    Evaluate tunnel positioning in femur and tibia and the graft integration and compare them between the 2 groups.

    Measured: 1 year post operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2020
  2. Study start2 Mar 2020
  3. Primary completionApr 2023 (estimated)
  4. Study completionApr 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two groups of patients, randomly assigned
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04366362
Sponsor's protocol ID
GC1
Acronym
IACLR
Status last verified
Nov 2021
First submitted
10 Jun 2019
Last updated
18 Nov 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Individualised ACL reconstruction and Conventional ACL reconstruction in people with Anterior Cruciate Ligament Injuries, run by Larissa University Hospital at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Georgios Chalatsis, MD (00306977992086, ghalatsis@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of the change of stability of the operated knee between the two groups from Baseline until 1 year post-operation (time frame: Baseline and 1 year post operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in